Toxicity Due to Chemotherapy
16
2
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (16)
Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers
Investigating Cardiovascular Adverse Events Related to Cancer Treatment
Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab
Pilot Study of an NTproBNP Guided Strategy of Cardioprotection
Dose Optimization and Efficacy Assessment of a Fluoropyrimidine Antidote
Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments
Impact of Gonadotoxic Therapies on Fertility
Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer
Systemic Treatment Related Toxicity Identified With a Smartphone APPlication Measuring Step Count
Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer
Optimized Multi-modality Machine Learning Approach During Cardio-toxic Chemotherapy to Predict Arising Heart Failure
Chemotherapy-related Toxicity, Nutritional Status and Quality of Life
Limiting Chemotherapy Side Effects by Using Moxa
Uridine Triacetate as Antidote for Patients at Excess Risk of 5-FU Toxicity Due to Overdosage or Impaired Elimination
Acupuncture for Chemotherapy-induced Peripheral Neuropathy
Chemotherapy Combined With Whole-body Hyperthermia to Treat Stage IIIB/IV Non Small Cell Lung Cancer